October 13, 2006
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that three executives in its Managed Markets Practice will play prominent roles at the Strategic Research Institute’s (
“This event is coming at an important time, as companies look to shape their Medicare strategies for 2007 and beyond. In the coming months, pharmaceutical companies will begin analyzing the first full year’s worth of senior enrollment data since the inception of Medicare Part D to help guide their contacting and pricing strategies. In addition, managed care organizations and pharmacy benefit managers will be conducting similar analyses to inform development of their bids to the Centers for Medicare and Medicaid Services next year. Critical decisions made early next year will drive success in 2008,” stated Kevin Barnett, Senior Vice President and head of its Managed Markets Practice.
Mr. Barnett will present a session titled “Understanding and Addressing the Short- and Long-Term Implications of Medicare Part D” on October 25 at 9:15 a.m., which will address the critical decisions pharma marketers must make in the areas of brand management, account management, contracting, pricing, and field sales.
Also on October 25, at , Steve Carter, Senior Practice Executive, will moderate a roundtable discussion titled “Impact of Patient Sensitivity to Out-of-Pocket Costs on Pricing and Reimbursement Decisions.” During this session, executives from
Lastly, Tony Lanzone, Senior Practice Executive, will present a session titled “Keys to Developing a Coordinated Channel Strategy for Managed Markets” on October 26 at The presentation will focus on identifying which managed markets channels (e.g., MCOs, PBMs, specialty pharmacy providers, long-term care facilities, hospitals and employers) are most important to manufacturers in order to position their products for success.
For more information on
About the Managed Markets Practice at